Podcasts about Bayer

Jordi Sánchez, CEO de Bayer Iberia, detalla la estrategia de la multinacional, su inversión en I+D y el compromiso con la sostenibilidad en España.

Bayer Leverkusen and Borussia Dortmund meet in a heavyweight Bundesliga fixture on Sunday, but only one of these teams is in need of the points.Bayer's title defence is now over after Bayern Munich wrapped up the league crown with a few games to spare and they have secured second spot irrespective of what happens in their final two games.In contrast, Dortmund have it all to play for as they sit in fifth spot but are just one point behind Freiburg in fourth.

This week's episode includes coverage from our team in Washington D.C. and an interview with an entrepreneur with over ten years in the soil health business. Our D.C. coverage includes insights and quotes from U.S. Secretary of Agriculture Brooke Rollins, EPA Administrator Lee Zeldin, NRCS Chief Aubrey J.D. Bettencourt, and USDA Chief Meteorologist Brad Rippey. Topics include recent U.S. trade wins, the latest developments on the Waters of the U.S. rule, government downsizing or what guests referred to as rightsizing and yet another delay in the Farm Bill markup. We also report on a new economic impact study on the biomass-based diesel industry and Bayer's decision to exit the seed treatment equipment market. In this month's interview, we hear what led Landom Oldham from Heartland Soil Services to starting the company over 10 years ago, the risks he had to take and how soil health awareness among farmers has grown. Oldham did not grow up on a farm, but now is actively involved in the agriculture industry and provides a planting update from the Kansas area. Stay connected with us for more agriculture content on Instagram, TikTok, Facebook, and YouTube, along with our weekly videos!

Andrea Picciotti-Bayer, Director of the Conscience Project, talks about a new law passed in the state of Washington that forces priests to break the seal of the confessional. Watch a short video about St. John Seminary's Online in M.A. in Pastoral Ministry Program: https://vimeo.com/79053099If you are interested in learning more about the online M.A. in Pastoral Ministry Program for lay students at St. John's Seminary, email Dr. Stuart Squires at mapm@stjohnsem.eduListen to the previous episode with Andrea: https://open.spotify.com/episode/4M36YkzQAAixeDCk3rhy3G?si=QqpVdDeCTZmf3hpAZmdBGw

Ponemos el foco en el DAX alemán, BP, Commerzbank, Mediobanca, EDP y Bayer, de la mano de Juan José del Valle, responsable del análisis de Activotrade.

Send us a textIs an Indian CDMO the right move for your biologics CMC development?Pulling back the curtain on what might be your next strategic manufacturing advantage, this episode reveals the hidden capabilities emerging from India that leading biotech companies are racing to access. As supply chain vulnerabilities continue to expose risks in traditional manufacturing models, could the solution lie halfway around the world?Joining us to reveal the inside story is Abdelaziz Toumi, CEO of Lupin Manufacturing Solutions and veteran of global pharma giants like Bayer, Merck and Lonza. With over 20 years in biotech, Abdelaziz brings unique insights on when and why you might want to look beyond traditional Western manufacturing partners. Our host, David Brühlmann, leverages his 15+ years of biotech industry experience to extract the practical insights you need to make informed decisions about your manufacturing strategy.In this second segment, we'll dive deeper into the Indian CDMO and biomanufacturing landscape. Then we'll explore Lupin's specialized capabilities and finally extract Abdelaziz's most valuable leadership insight from his role as a CEO.Key insights from this episode:The One-Stop Solution Advantage: Discover how Lupin is building rare end-to-end manufacturing capabilities for complex modalities like Antibody-Drug Conjugates (ADCs) - potentially eliminating the headache of managing multiple manufacturing partners across continents.Beyond Labor Cost Advantages: "Digitalization plays a key role, especially if you are operating in a cost-competitive space," explains Abdelaziz. Learn how Indian CDMOs are strategically automating key processes to drive both efficiency and quality, challenging Western perceptions.Leadership Across Cultures: "Listen, listen, listen," emphasizes Abdelaziz when discussing cross-cultural leadership. Understand the subtle communication dynamics that can make or break a global manufacturing partnership, especially when navigating hierarchy-sensitive cultures.Whether you're actively evaluating Indian manufacturing options or simply preparing for the shifting global biotech landscape, these next several minutes deliver insights you can't afford to miss.Listen to the full episode to extract the specific capability indicators that will help you determine if and when an Indian CDMO partnership makes strategic sense for your unique biologics pipeline.Want to find out more about the CDMO selection? Here's what one of our distinguished guests had to say about it:Episodes 103-104: One-Stop Shop vs. Specialist CDMO: A Scientist's Guide to CDMO Selection with Sigma MostafaConnect with Abdelaziz Toumi:LinkedIn: www.linkedin.com/in/abdelaziztoumiLupin Manufacturing Solutions: www.lupin.comNext step:Transform your process development strategy with a complimentary consultation. Schedule your expert session: https://bruehlmann-consulting.com/callReady to scale up? Join our exclusive 1:1 Strategy Call and learn proven methods to reduce development and manufacturing costs while maintaining product quality. Our bioprocess experts will help you navigate complex bioprocessing challenges and regulatory requirements. Limited spots available: https://stan.store/SmartBiotech

This episode covers: Cardiology This Week: A concise summary of recent studies Colchicine for secondary prevention An algorithmic approach to the workup of syncope Milestones: CIBIS II Host: Rick Grobbee Guests: Carlos Aguiar, Sanjit Jolly, Michele Brignole Want to watch that episode? Go to: https://esc365.escardio.org/event/1805 Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests: Stephan Achenbach, Michele Brignole, Diederick Grobbee and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Sanjit Jolly has declared to have potential conflicts of interest to report: grant support from Boston Scientific, honorarium from Boston Scientific, Shockwave, Abiomed, SIS, and Teleflex.  Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Host: Rick Grobbee Guest: Michele Brignole Want to watch that extended interview? Go to: https://esc365.escardio.org/event/1805?r  Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests: Stephan Achenbach, Michele Brignole, Diederick Grobbee and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

The epigenome is essentially the control software for plants and animals that dictates when, where, and to what level different genes in the genome are expressed. Moderating the epigenome has the potential to upgrade crops in real time, during the season, to adjust photosynthesis and warn crops of upcoming droughts, diseases, or other threats. While traditional plant breeding and genetics requires trait selections to be made prior to planting and establishing the crops, epigentics enables these traits to be managed after the plant is already growing. Today we are joined by Travis Bayer who recently founded Decibel Bio to develop spray on  epigenetic instructions that enable a new level of control over crop traits.Travis and Decibel are leading the development of highly targeted epigenetic innovations for crops while other startups are looking at epigenetic reprograming to develop human therapeutics.  Send us a text

Send us a textIs an Indian CDMO the right move for your biologics pipeline?As Western biotech companies seek new strategic advantages, one question keeps surfacing: Is India truly becoming the next biotech manufacturing powerhouse? And what hidden capabilities are emerging that leading companies are racing to access?In this episode of the Smart Biotech Scientist Podcast, Abdelaziz Toumi, CEO of Lupin Manufacturing Solutions and veteran of global pharma giants like Bayer, Merck, and Lonza, joins host David Brühlmann to reveal the inside story on when and why you might want to look beyond traditional Western manufacturing partners.Here are three key insights from their conversation:The Post-Pandemic Manufacturing Revelation: "During the pandemic, we realized how vulnerable our supply chain truly is," explains Abdelaziz. Discover why diversifying manufacturing partnerships isn't just smart—it's becoming essential for resilience in an unpredictable world.Beyond the Cost Advantage: While Indian CDMOs can deliver up to 80% cost savings compared to Western counterparts, Abdelaziz reveals the unexpected advantages that make the most strategic partnerships about far more than budget considerations.The Trust Factor: "This is a business of trust," emphasizes Abdelaziz. Learn the critical questions that separate world-class Indian CDMOs from the rest, and the cultural nuances that can make or break your manufacturing partnership.Ready to discover if Indian CDMOs could be the missing piece in your biologics development strategy? Tune in for expert insights on IP protection, talent access, and how to navigate the cultural dynamics that determine success in this emerging manufacturing powerhouse.Listen to the full episode to unlock the strategic advantage that could transform your pipeline's journey from lab to market.Want to find out more about the CDMO selection? Here's what one of our distinguished guests had to say about it:Episodes 103-104: One-Stop Shop vs. Specialist CDMO: A Scientist's Guide to CDMO Selection with Sigma MostafaConnect with Abdelaziz Toumi:LinkedIn: www.linkedin.com/in/abdelaziztoumiLupin Manufacturing Solutions: www.lupin.comNext step:Transform your process development strategy with a complimentary consultation. Schedule your expert session: https://bruehlmann-consulting.com/callReady to scale up? Join our exclusive 1:1 Strategy Call and learn proven methods to reduce development and manufacturing costs while maintaining product quality. Our bioprocess experts will help you navigate complex bioprocessing challenges and regulatory requirements. Limited spots available: https://stan.store/SmartBiotech

The potential for real world evidence (RWE) is huge, according to enthusiasts, but to the uninitiated it can seem like a complicated and forbidding subject. In this Over the Counter double episode, IQVIA Consumer Health's vice president of global research and development and real-world evidence services, Volker Spitzer, makes understanding real world evidence easy. We start with the basics, with what it is and what companies need to know about it, and what the key difference is with randomised control trials. Many companies are already using real world evidence, Volker notes, and he extracts some key lessons for companies interested in trying it out based on his extensive experience working with industry on such projects. Timestamps 2:00 – Introductions 4:00 – What is real world evidence? 5:00 – Can RWE and clinical trials complement each other? 10:00 – Why RWE is particularly attractive today 14:00 – Don't reinvent the wheel 18:00 – Why is this important for consumer health companies? 25:00 – Why RWE is often a good value option, especially for SMEs 33:00 – Applications of RWE in consumer health Guest Bio Volker Spitzer has more than 30 years of R&D experience spanning the consumer health sector, ingredients industry, and academia. Beginning his career as a professor in pharmaceutical sciences, he ascended to global positions encompassing R&D, innovation, licensing/M&A, and medical marketing at firms like Roche, DSM Nutritional Products, and Bayer. Since October 2017, Volker has been affiliated with IQVIA Consumer Health, serving as the vice president for global R&D and RWE Services. His purview primarily includes clinical research, RWE, virtual trials, and the burgeoning field of digital health. He has penned over 80 scientific publications, whitepapers and textbooks centered on science and innovation.

Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc.

#EP288 MAP “O impacto da IA no cotidiano com Gustavo Melles”No episódio de hoje, eu, Professor Rogério Coimbra, converso com o especialista em inovação Gustavo Melles sobre “O impacto da IA no cotidiano”.Com mais de 25 anos de experiência nas áreas de comunicação e tecnologia, Gustavo compartilha sua visão sobre como a inteligência artificial está transformando o dia a dia das pessoas, dos negócios e, claro, também do Agronegócio.Fundador dos portais BuscalA.com e OiRobo.com, ele também é professor no MBA em Inovação e Inteligência Artificial para Negócios da PUCPR, e já colaborou com gigantes como Bayer, Toyota, Natura, Uber e Cielo.Neste bate-papo, falamos sobre como a IA pode gerar soluções intuitivas, eficazes e de valor real — tudo isso com foco em experiência do usuário e aplicabilidade prática.Dá o play e vem com a gente entender como a tecnologia está moldando o presente e o futuro! ▶️Instagram convidado:Instagram (@gusmelles)Parceiro Institucional:MOMESSO: Momesso | Máquinas de Tratamento para SementesMomesso | Máquinas de Tratamento para SementesAgro-Sol Sementes:Agro-sol Sementes e Cultivares de Soja em Mato Grosso. - Agro-sol Sementes ](Agro-sol Sementes e Cultivares de Soja em Mato Grosso. - Agro-sol SementesIncotec:Seed Enhancement - Specialists in Seed Technology | Incotec ](Seed Enhancement - Specialists in Seed Technology | Incotec

Banco Sabadell mira a los 2,7€ como próximo nivel relevante, a la espera de una mejora en la opa de BBVA. Con Josep Codina. Además, las perspectivas de Banco Santander, Telefónica y Grifols en la bolsa española, las de Bayer y Siemens en las bolsas europeas, y las de Microsoft, IBM y Take Two en Wall Street. Más información: https://www.finanzas.com/inversion/podcasts/banco-sabadell-ibex-35/

Fußballlehrer Heiko Herrlich war Bundesliga- Trainer von Bayer 04 Leverkusen, dem VfL Bochum und dem FC Augsburg. Seine letzte Station war Anfang 2025 bei der SpVgg Unterhaching in der 3. Liga.Im zweiten von drei Teilen reden wir darüber, warum der Ex- Profi als Trainer seine Spieler im Training auch bewusst weit über die Schmerzgrenze hinaus belastet und wie genau seine Herangehensweise dabei ist.Außerdem wird eines der legendärsten Spiele der Bundesliga- Geschichte Thema sein, als Heiko Herrlich 1999 mit dem BVB den FC Bayern München empfing und Torwart -Legende Oliver „Kung Fu“ Kahn ganz bewusst provozierte, bis Kahn dann schließlich Herrlichs Ohr knabberte o. ä. Unfassbar spannend wird es aus sportwissenschaftlicher Sicht, wenn Herrlich über die Mobilisationsschwelle von Oliver Kahn und Profi- Sportlern spricht und wie man sich in den „richtigen“ Zustand dafür bringt.___Gefällt Dir das Format und möchtest Du auch einmal mit Bundesligatrainern am virtuellen Stammtisch reden? Dann unterstütze uns bitte, IKDT am Leben zu erhalten, komm in den PREMIUM SUPPORTERS CLUB und sichere Dir als Dankeschön exklusive Vorteile. Alle Infos dazu erhältst Du in Podcastfolge #165.Für weitere Informationen zu Gesprächspartnern, Gewinnspielen oder dem direkten Draht in die Sendung folge einfach unseren Social Media Kanälen:Youtube: Im Kopf des TrainersTik Tok, Instagram & Facebook: @imkopfdestrainersTwitter: Stephan Schäublewww.imkopfdestrainers.dewww.schaeuble-tv.dewww.das-prisma.deHerzlichstDein Stephan

Send us a textHealth coaching is often overlooked in healthcare, but could it be the key to improving behavior change, supporting chronic care, and filling gaps left by clinical shortages? In this episode of CareTalk: Healthcare. Unfiltered., Eugene Borukhovich, COO & Co-Founder of YourCoach, joins John Driscoll to discuss why coaching is gaining traction, how YourCoach is helping scale it, and why embracing health coaches could be critical to building a stronger, more sustainable healthcare system.

Im Mai dreht sich im brand eins Podcast alles rund um den Arbeitsmarkt, „Ach, Mensch!“ geht in die nächste Staffel, Antritt bekommt eine neue Serie und Christian und Stephan ziehen eine kleine Vier-Tage-Woche-Bilanz. (00:00:00) Intro und Begrüßung Stephan Ziegert (00:00:44) Der erste Mai bei detektor.fm (00:02:01) Der „Talentmarktplatz“ bei Bayer als Thema im brand eins Podcast (00:07:14) Über Selbstständigkeit im brand eins Podcast (00:10:11) Wie läuft die 4-Tage Woche bei detektor.fm? (00:15:25) Über Optimierungsprozesse im brand eins Podcast (00:16:27) Neue Staffel Ach Mensch (00:17:30) Neue Serie „Das Rad meiner Träume“ im Antritt (00:18:50) Die Mai Empfehlungen (00:28:08) Verabschiedung Hier geht’s zum brand eins Podcast. Hier geht’s zu „Ach, Mensch!“. >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/destilliert-mai-2025-arbeitsmarkt-brand-eins-podcast-neue-staffel-ach-mensch

Im Jahr sieben nach der Monsanto-Übernahme ist der Leverkusener Traditionskonzern in den Dauerkrisenmodus gerutscht. Findet Konzernchef Bill Anderson einen Ausweg oder droht Bayer das Schicksal des einstigen Konkurrenten Hoechst – das Verschwinden? Weiterführende Links: Interaktive Grafik: Hier sehen Sie, wie die Monsanto-Last Bayer erdrückt Brandbrief vom Boss: So gefährdet die Agrarsparte das Überleben von Bayer Monsanto-Reste: Eine Bad Bank für Glyphosat – die Pläne des Bayer-Chefs Crop-Science-Chef geht: Bayer trennt sich von Monsanto-Veteran Bob Reiter Vordenker Gary Hamel: Er ist das Mastermind hinter dem Konzernumbau bei Bayer Zum manager magazin Abo Der Tag – Die Wirtschaftsnachrichten als Newsletter Das manager magazin fasst den Tag für Sie zusammen: Die wichtigsten Wirtschaftsnachrichten im Überblick. Täglich ab 18:00 Uhr. Hier geht es zur Anmeldung! Dieser Podcast wurde produziert von Felix Klein, Selina Hegger und Sven Bergmann.+++ Alle Infos zu unseren Werbepartnern finden Sie hier. Die manager-Gruppe ist nicht für den Inhalt dieser Seite verantwortlich. +++ Alle Podcasts der manager Gruppe finden Sie hier. Mehr Hintergründe zum Thema erhalten Sie bei manager+. Jetzt drei Monate für nur € 10,- mtl. lesen und 50% sparen manager-magazin.de/abonnieren Informationen zu unserer Datenschutzerklärung.

Im Mai dreht sich im brand eins Podcast alles rund um den Arbeitsmarkt, „Ach, Mensch!“ geht in die nächste Staffel, Antritt bekommt eine neue Serie und Christian und Stephan ziehen eine kleine Vier-Tage-Woche-Bilanz. (00:00:00) Intro und Begrüßung Stephan Ziegert (00:00:44) Der erste Mai bei detektor.fm (00:02:01) Der „Talentmarktplatz“ bei Bayer als Thema im brand eins Podcast (00:07:14) Über Selbstständigkeit im brand eins Podcast (00:10:11) Wie läuft die 4-Tage Woche bei detektor.fm? (00:15:25) Über Optimierungsprozesse im brand eins Podcast (00:16:27) Neue Staffel Ach Mensch (00:17:30) Neue Serie „Das Rad meiner Träume“ im Antritt (00:18:50) Die Mai Empfehlungen (00:28:08) Verabschiedung Hier geht’s zum brand eins Podcast. Hier geht’s zu „Ach, Mensch!“. >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/destilliert-mai-2025-arbeitsmarkt-brand-eins-podcast-neue-staffel-ach-mensch

Food Tank, in partnership with the Sprouts Healthy Communities Foundation, recently hosted a special series on “Food is Medicine and Eating for Health.” This webinar features conversations from Part 1 of the event as panelists come together to discuss what it means to implement holistic approaches to improving access to healthy, nourishing foods; the empowerment of youth; and how we ensure that the opportunities presented by Food is Medicine aren't wasted. Speakers include Erika Allen, Urban Growers Collective; Dr. Kofi Essel, Elevance Health; Rachel Fisher, U.S. Department of Health and Human Services; Kathleen Merrigan, Swette Center for Sustainable Food Systems at Arizona State University; A-dae Romero-Briones, First Nations Development Institute; Alice Waters, American chef, restaurateur, and author; and Lyndsey Waugh, Sprouts Healthy Communities Foundation. Plus, hear about the staffing cuts expected at the world's largest humanitarian organization, the push for countries to release their updated climate action plans, and the new legislation that could make it harder to win a legal case against the agrochemical company Bayer.  While you're listening, subscribe, rate, and review the show; it would mean the world to us to have your feedback. You can listen to “Food Talk with Dani Nierenberg” wherever you consume your podcasts.

Mit  Rüdiger Bachmann und Christan Bayer, der die Einreise in die USA überstanden hat. US-Daten BEA: Gross Domestic Product, 1st Quarter 2025 (Advance Estimate) Bachmann et.al.: Identifying Monetary Policy Shocks Using the Central Bank's Information Set Koalitionsvertrag CDSU-Kabinettsmitglieder (designiert) Steinkühlerpause

Der VfL Bochum könnte heute aus der Bundesliga absteigen. Tausende Fans machten der Mannschaft beim Abschluss-Training Mut. Eintracht Frankfurt möchte im Sommer einige Spieler lsowerden. Wir schauen uns die Streichliste an und Bayer Leverkusen soll sich in Italien mit Cesc Fabregas getroffen haben.

Leipzig Outclassed by Eintracht, Controversial Dortmund Win, 7-Goal Stunner in KielThe Topspiel and Champions League spot on the line saw Eintracht Frankfurt rise to the occasion and maul Leipzig 4-0, who tumble out of the top 4. Dortmund won it late amidst Hoffenheim complaints and moved within 3 points of fourth place. Elsewhere, Bayern and Bayer won to postpone title celebrations for at least another matchday. Complete opposite in the 2. Bundesliga, where number 1 to 10 can still win the league and promotion!

In der neuen Ausgabe des Transfermarkt-Podcasts „DONE DEALS – der Transfermarkt-Podcast“ sprechen die Hosts Fabian Knottnerus und Lennart Gens über die spannendsten Trainer-Gerüchte der Woche. Carlo Ancelotti stand schon unmittelbar vor einem Engagement als Nationaltrainer Brasiliens. Nun scheint es den Italiener aber doch nach Saudi Arabien zu ziehen. Da sein Abgang von Real Madrid immer wahrscheinlicher wird, wird jetzt auch wieder vermehrt Xabi Alonso mit den Königlichen in Verbindung gebracht. Im Falle eines Abganges beschäftigt sich Bayer 04 Leverkusen schon jetzt mit möglichen Nachfolgern – wer passt am besten zur Werkself? Wir machen den Check.

With new bladder cancer therapies on the horizon, Dr. Lalani and Dr. Wallis review promising trial results - including EVER, CREST and the CISTO Study -presented at this year's annual meeting. They also address key practical challenges for bladder cancer treatment, from both a medical oncologist and a urologic oncologist's perspective.The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: theviewongu.caThis podcast has been made possible through unrestricted financial support by Novartis, Bayer, Astellas, Tolmar, J&J, Merck, Pfizer, Eisai and AbbVie.

*Mexico is not cooperating in the fight against screw worms.  *Bayer may stop producing Roundup.*Spring planting is underway in the Texas Panhandle.  *A new bill is under consideration in Congress to make it easier for ranchers to protect their livestock from black vultures.  *Angus genetics make up a vast majority of the U.S. cow herd.  *Chicken litter is a popular source of pasture fertilizer in Central and East Texas. *It's very important to clean feeding equipment for dairy calves.  

Bayer steckt mitten in der Transformation und tut sich schwer. Die Rechtsrisiken rund um das Unkrautvernichtungsmittel Glyphosat sind nicht aus der Welt zu schaffen. Was bedeutet das für Aktionäre?

Xabi Alonso und Bayer Leverkusen: Diese befruchtende Partnerschaft neigt sich wohl dem Ende. Eure Hosts Mario, Matthias und Niklas sprechen über eine gewisse Unvermeidbarkeit dieser Trennung, aber auch über Dortmunder und Leipziger Parallelen, das Schöne an Holstein Kiel und Michael Olise als Nachfolger von Arjen Robben. Hört rein!

Xabi Alonso und Bayer Leverkusen: Diese befruchtende Partnerschaft neigt sich wohl dem Ende. Eure Hosts Mario, Matthias und Niklas sprechen über eine gewisse Unvermeidbarkeit dieser Trennung, aber auch über Dortmunder und Leipziger Parallelen, das Schöne an Holstein Kiel und Michael Olise als Nachfolger von Arjen Robben. Hört rein!

Aktien hören ist gut. Aktien kaufen ist besser. Bei unserem Partner Scalable Capital geht's unbegrenzt per Trading-Flatrate oder regelmäßig per Sparplan. Alle weiteren Infos gibt's hier: scalable.capital/oaws. Aktien + Whatsapp = Hier anmelden. Lieber als Newsletter? Geht auch. Das Buch zum Podcast? Jetzt lesen. Alphabet verdient einmal Lufthansa mit SpaceX. Waymo & Tesla feiern. BYD macht Gewinn. Deliveroo kriegt DoorDash-Angebot. Toyota will Toyota kaufen. Safran pusht MTU. China pusht Safran. Spotify wird teurer. Deutsche Telekom sinkt. Bayer (WKN: BAY001) macht eine Kapitalerhöhung mit einem Drittel seines Börsenwerts. Die Börse feiert trotzdem. Wie kann das sein? Zölle? Apple (WKN: 865985) produziert einfach alle iPhones in Indien. Aber ist das so easy? Wir klären auf. Diesen Podcast vom 28.04.2025, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung.

Historic moves out of Washington D.C., as HHS Secretary Robert F. Kennedy Jr. announces his fight to find the cause of autism, and new FDA Commissioner Dr. Marty Makary takes action to remove toxic additives and dyes from our food. Jefferey Jaxen reports on the White House embracing lab leak theory, the bleak future of Bayer's Roundup, and new cancer risks associated with COVID vaccines—just as the federal government begins to reverse its stance. New Bill Makes Health History in Tennessee. Finally, retired pediatrician Dr. Paul Thomas shares his journey from vaccine advocate to whistleblower in his new book, ‘Vax Facts.'Guests: Bernadette Pajer, Dr. Paul Thomas#TheHighWire #RFKJr #MartyMakary #FoodDyeBan #VaccineSafety #COVIDVaccine #AutismAwareness #PaulThomasMD #Glyphosate #Roundup #HealthFreedom #LabLeakBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

In today's show Dustin learns about the latest herbicide technology from Cody Gray of UPL, Andy gets a planting preview from Iowa Corn President Stu Swanson, and Riley learns about the new herbicide, Convintro, from Bayer's Dominik Hoffmann.

La opinión de Raúl Varela, presentador de La Tribu, este viernes, sobre el futuro de Xabi Alonso, el entrenador del Bayer.See omnystudio.com/listener for privacy information.

https://youtu.be/79fT9VIDkVs Podcast audio: As Ayn Rand wrote, “The concept of individual rights is so prodigious a feat of political thinking that few men grasp it fully—and two hundred years have not been enough for other countries to understand it.” We can see this failure of understanding in the view, advanced by many conservatives and libertarians today, that the concept of individual rights ultimately derives from or is at least consistent with the Judeo-Christian morality. In this talk, Ben Bayer explores some highlights of the history of the concept to understand why it is essentially a secular innovation, even when thinkers who helped advance it held Christian views. He especially focuses on how Enlightenment views of human nature and knowledge helped untether “rights” discourse from its antecedents in religious thought. Recorded live on June 17 in Anaheim, CA as part of OCON 2024.

Host: Emer Joyce Guests: Joost Lumens and Nico Bruining Want to watch that extended interview? Go to: https://esc365.escardio.org/event/1804?resource=interview Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.  Declarations of interests: Stephan Achenbach, Nico Bruining, Emer Joyce and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Joost Lumens has declared to have potential conflicts of interest to report: research grants from Medtronic (all grants paid to institute, Maastricht University). Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

This episode covers: Cardiology This Week: A concise summary of recent studies Hypertension in the elderly The digital twin in cardiology Snapshots Host: Emer Joyce Guests: Carlos Aguiar, Gianfranco Parati, Nico Bruining, Joost Lumens Want to watch that episode? Go to: https://esc365.escardio.org/event/1804 Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests: Stephan Achenbach, Nico Bruining, Emer Joyce and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Joost Lumens has declared to have potential conflicts of interest to report: research grants from Medtronic (all grants paid to institute, Maastricht University). Gianfranco Parati has declared to have potential conflicts of interest to report: honoraria for lectures by Omron, Merck, Viatris, Somnomedics. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

On the HAT Podcast Eric Pfeiffer and C.J. Miller have the news including what the fallout would be if Bayer stopped producing glyphosate, and what does planting progress look like in southern Indiana so far this spring? HAT Chief Meteorologist Ryan Martin says mostly dry today except possibly in the north, and dry tomorrow too. Grain and oilseed markets were mixed Tuesday as soybeans worked a little higher. Andy Eubank has settlements and analyst Arlan Suderman provides market commentary. It's all part of the #HATPodcast, made possible by First Farmers Bank & Trust - proudly serving local farms, families, and agribusiness for 140 years. Visit them online at FFBT.com to learn more.

Da hat uns der Osterhase aber einmal ein paar Eier ins Nest gelegt! Mit etwas Verspätung liefern wir nach den Feiertagen unsere Besprechung des 30. SPIELTAGs nach. Dabei stößt ein besonderer Gast zu uns: Lena Cassel (u.a. DAZN) spricht mit uns über ihr neues Buch "Aufstiegskampf". Außerdem ist sie als Moderatorin und Expertin eine echte Bereicherung für unsere BUNDESLIGA-SPIELTAGSBESPRECHUNGEN. Zusammen mit Etienne, Tobi und Niko kämpft sie sich durch alle Partien. Los geht es mit dem Titel"rennen": BAYERN MÜNCHEN hat nach dem 4:0-Sieg gegen HEIDENHEIM den Titel fast in der Tasche. Der Schmerz nach dem Aus gegen INTER MAILAN scheint verfolgen. In LEVERKUSEN hingegen geht nicht mehr viel: BAYER schenkt mit dem 1:1 gegen den FC ST. PAULI quasi den Titel her. Droht der noch-amtierende Double-Sieger im Sommer auseinanderzufallen? Spannung gibt es vor allem im Rennen um Europa. Etienne ärgert sich über das 0:0 seiner EINTRACHT gegen den FC AUGSBURG. BORUSSIA DORTMUND wiederum marschiert die Tabelle nach oben. Schaffen sie noch die CHAMPIONS LEAGUE-Qualifikation? Und was wird aus Nikos Lieblingsverein WERDER BREMEN? Wir werfen die Glaskugel an und schauen auf das Restprogramm der EUROPAPOKALl-Kandidaten! Rocket Beans wird unterstützt von Sketchers. ►Ihr wollt Lena live erleben? Hier findet ihr alle Infos zu ihrer Lesetour! [Link weiter unten]!

Sermon delivered on Easter Sunday, 2025, in Harrisburg, Pennsylvania, by Rev. Tobias Bayer. Epistle: 1 Cor. 5, 7-8. Gospel: St. Mark 16, 1-7.

Mark Bayer spent 20 years in the U.S. Congress shaping major policies and managing high-stakes communication for senior lawmakers. In Part Two, Mark gets practical—breaking down the actual tools and mindset shifts PhDs need to thrive in the private sector. From his 11 Keys to Translating Complexity (complexitymadeclear.com) to why metaphors matter more than models, he shows how scientists can go from overlooked to unforgettable. Plus, what AI can't do—and why your human voice still matters more than ever.This one's for anyone who's been told their skills are “too academic.” Turns out, they're your superpower—if you know how to use them.Key Highlights of Our Interview:The “11 Keys” Framework“Shakespeare said, brevity is the soul of wit. But it's also the start of strategy.”Wake Words and Brain Wiring“Our brains tune into the unexpected. Use that to your advantage.”Crossing Cultures & Languages“Being bilingual helps you distill ideas—and respect your audience's world.”The Real Meaning of Connection“You have to connect before you communicate. That's not soft—it's strategy.”AI Can't Replicate Your Voice“AI pulls from old ideas. Your job is to bring something new, human, and surprising.”_____________________Connect with us:Host: Vince Chan | Guest: Mark Bayer  --Chief Change Officer--Change Ambitiously. Outgrow Yourself.Open a World of Expansive Human Intelligencefor Transformation Gurus, Black Sheep,Unsung Visionaries & Bold Hearts.12 Million+ All-Time Downloads.Reaching 80+ Countries Daily.Global Top 3% Podcast.Top 10 US Business.Top 1 US Careers.>>>140,000+ are outgrowing. Act Today.

Mark Bayer spent 20 years in the U.S. Congress shaping major policies and managing high-stakes communication for senior lawmakers. In Part One, he reflects on what those years taught him about messaging, persuasion, and why most PhDs—despite their brilliance—struggle to translate their value. From Capitol Hill to Harvard Medical School, Mark now helps scientists and researchers communicate like insiders.This episode is a masterclass in what PhDs get wrong—and what they already have right.Key Highlights of Our Interview:The First “R&D” Mix-up“I thought they were talking about research and development. But it was Republicans and Democrats.”The 8% Problem“Only 8% of PhDs stay in academia. But nearly all are trained as if that's the only path.”Misunderstood Advantage“PhDs are analytical, resilient, focused—yet many don't see those as selling points.”Beauty vs. Relevance“Beauty is in the eye of the beholder. Importance is in the eye of the stakeholders.”Your Message Has 10 Seconds“Lead with the punchline. Or your audience will drift.”Why Communication ≠ Dumping Data“Scientists want to show everything they know. But that's not the job. The job is to answer the question.”_____________________Connect with us:Host: Vince Chan | Guest: Mark Bayer  --Chief Change Officer--Change Ambitiously. Outgrow Yourself.Open a World of Expansive Human Intelligencefor Transformation Gurus, Black Sheep,Unsung Visionaries & Bold Hearts.12 Million+ All-Time Downloads.Reaching 80+ Countries Daily.Global Top 3% Podcast.Top 10 US Business.Top 1 US Careers.>>>140,000+ are outgrowing. Act Today.

FDA and Big Pharma Conflict of Interest (0:00) Bayer's Historical Misconduct and Glyphosate Toxicity (2:13) Health Ranger Store's Glyphosate Testing (4:54) Trump's Rejection of Netanyahu's Iran Attack Plan (6:28) Florida State University Shooting and Anti-Trump Protests (11:14) Blue Origin Rocket Launch and Media Fakery (14:29) Microscopy Analysis of Chemtrails and Heavy Metals (26:23) Incubation Results and Potential Pandemic (46:56) Call to Action and Conclusion (51:28) Preparation for a Post-Human Future (52:09) Economic Challenges and Health Ranger Store Promotions (1:16:03) Weaponization of the Air (1:20:17) Historical Context of Climate Change and Chemtrails (1:23:22) Health Implications and Defenses Against Chemtrails (1:30:45) Personal Protective Measures and Future Predictions (1:35:58) Project Paperclip and Nazi Influence in US Institutions (1:46:14) Critique of NASA and Moon Landings (2:07:46) UFOs, MJ 12, and Government Involvement (2:14:18) Health Ranger Store Product Highlights (2:28:10) For more updates, visit: http://www.brighteon.com/channel/hrreport  NaturalNews videos would not be possible without you, as always we remain passionately dedicated to our mission of educating people all over the world on the subject of natural healing remedies and personal liberty (food freedom, medical freedom, the freedom of speech, etc.). Together, we're helping create a better world, with more honest food labeling, reduced chemical contamination, the avoidance of toxic heavy metals and vastly increased scientific transparency. ▶️ Every dollar you spend at the Health Ranger Store goes toward helping us achieve important science and content goals for humanity: https://www.healthrangerstore.com/ ▶️ Sign Up For Our Newsletter: https://www.naturalnews.com/Readerregistration.html ▶️ Brighteon: https://www.brighteon.com/channels/hrreport ▶️ Join Our Social Network: https://brighteon.social/@HealthRanger ▶️ Check In Stock Products at: https://PrepWithMike.com

In this explosive episode of Talk Dirt to Me, we break down the latest in the U.S.–China tariff war and what it means for American farmers. Will China's retaliation cripple ag exports, or is U.S. grain still a global necessity? We unpack the facts and share where we stand. Then we tackle the bombshell news that Bayer may drop Roundup if the government doesn't grant them litigation protection. Could this shake the entire ag industry? We explore the real-world ramifications, whether Roundup truly causes cancer, and what farmers could be forced to use instead. Plus, we take on some sharp listener questions and shine a spotlight on this week's Made in America segment: Pak Mule — the ultimate American-built cargo rack system designed for those who live hard and haul heavy. Whether you're in the cab or the shop, this is the kind of raw, unfiltered ag conversation you won't get anywhere else. Made in America Feature: https://pakmule.com/ Agzaga is the official sponsor of Talk Dirt to Me! It is the ultimate online farm store. American owned and operated. Go check out their site and get what you need. Be sure to use the code TALKDIRT to get 10% off your order! Visit them at: https://agzaga.com  If you enjoy this episode then please leave us a review and share this episode with your friends! Follow us on social media: Talk Dirt to Me Instagram: https://www.instagram.com/talkdirtpodcast/  Bobby Lee: Facebook- https://www.facebook.com/search/top?q=hurricane%20creek%20farms Instagram- https://www.instagram.com/hurricanecreekfarm/ YouTube- https://www.youtube.com/c/HurricaneCreekFarms Logan: Facebook- https://www.facebook.com/LHFarmsTN Instagram- https://www.instagram.com/lo.hanks/ YouTube- https://www.youtube.com/channel/UCqYpTjKQtOMABFOc2Aw3_Ow 

In this episode of the Ag Tribes Report, host Vance Crowe welcomes JR Burdick, a raw milk farmer known for his advocacy of local food sovereignty and traditional values. Together, they delve into pressing issues affecting the agriculture sector, including Bayer's potential halt of RoundUp production due to costly lawsuits, and the implications of Trump's tariffs aimed at isolating China. The discussion also covers the American beverage industry's reaction to SNAP benefit restrictions and the potential impact of UK cheese tariffs on US markets. JR shares his insights on the consolidation of the ag industry and the potential for a return to smaller farms, while also highlighting the importance of responsible use of agricultural tools like glyphosate.The episode also features the Bitcoin land price report, where Vance and JR discuss the current value of Bitcoin in relation to farmland prices. JR shares his unique perspective on the Peter Thiel paradox, arguing that the consolidation in the ag industry is over, and highlights Joel Salatin as a worthy adversary. The episode concludes with a heartfelt story about JR's mother and a discussion on the value of capturing family legacies. Tune in for an engaging conversation that challenges conventional perspectives and explores the future of agriculture.

On this Good Friday holiday we have a new Friday Free-for-all featuring ag policy analyst Jim Wiesemeyer and RealAgriculture's Shaun Haney. Topics include trade, tax cuts plus ag bills in Washington, Bayer making glyphosate, and more.See omnystudio.com/listener for privacy information.

Big Pharma is under fire. A judge just rejected Johnson & Johnson's $10 billion talc settlement offer, and Bayer faces a stunning $2.1 billion loss in a Roundup lawsuit. Now, both companies are scrambling for immunity from future legal blowback across the U.S.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

Bayer hints that it may stop making glyphosate in the U.S. sooner rather than later. We'll take a closer look at why and what it means for agriculture. Plus, a solar flare could impact planting and looking at potential meat demand in Africa.See omnystudio.com/listener for privacy information.

Joe's Premium Subscription: www.standardgrain.comGrain Markets and Other Stuff Links-Apple PodcastsSpotifyTikTokYouTubeFutures and options trading involves risk of loss and is not suitable for everyone.0:00 China Digs In2:27 US Crop Progress5:05 Futures Industry Consolidation9:12 Bayer to Ditch Roundup?10:37 Russian Wheat Prices Dip11:36 Grain Shipments12:41 Corn Sale to JapanChina Orders Halt on US Aircraft Purchases ✈️

A conversation with Herb Young, farmer who, after 36 years in the chemical industry working for Bayer, retired and bought a small farm in Georgia—where things quickly got out of hand. While researching organic premiums, Herb came across regenerative agriculture—and fell deep, very deep, down the rabbit hole. For over a year, he read everything, listened to everything, and then planted his first trees. A few years later, Herb is now one of the leading regenerative citrus growers in the country, conducting cutting-edge research while selling his first harvest directly to consumers in over 36 states. And the most surprising part? His citrus is, on average, eight times more nutrient- dense than conventionally grown oranges. That means you'd have to eat eight regular oranges to match the nutrients of just one of his. Suddenly, the idea of food as medicine becomes very affordable. And, of course, his citrus is incredibly tasty. We also discuss his history in the agrochemical industry, what his former colleagues think of his new "hobby" and what excites him most about the upcoming second season.More about this episode on https://investinginregenerativeagriculture.com/herb-young.==========================In Investing in Regenerative Agriculture and Food podcast show we talk to the pioneers in the regenerative food and agriculture space to learn more on how to put our money to work to regenerate soil, people, local communities and ecosystems while making an appropriate and fair return. Hosted by Koen van Seijen.==========================

Hoje Dane Bayer, João Carvalho e Príncipe Vidane vão retornar à um grande clássico do Decrépitos: Os TESTES DA REVISTA CAPRICHO!Assine o plano BOGA VIVA e participe do nosso GRUPO SECRETO NO TELEGRAM! FINANCIE ESTE VACILO:apoia.se/decrepitosMANDA PIX:livepix.gg/decrepitosPARTICIPE PELO E-MAIL:ouvinte@decrepitos.comANUNCIE COM A GENTE:comercial@decrepitos.com